Skip to main content

Young Caroline's Form 4 filing

Cumberland Pharmaceuticals Inc (CPIX) ยท filed Sep 10, 2021

Accession no.
0001209191-21-055494
Filed
Sep 10, 2021
Trade date
Aug 2-31, 2021
Filing delay
39 daysLate
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 21 non-derivative transactions. Open-market purchases total $938.1. It was filed 39 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Young CarolineCIK 0001684087Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 2, 2021Common StockPPurchaseAcquired+15$3.34+$50.113,058Direct
Aug 3, 2021Common StockPPurchaseAcquired+15$3.17+$47.5513,073Direct
Aug 4, 2021Common StockPPurchaseAcquired+15$3.18+$47.713,088Direct
Aug 5, 2021Common StockPPurchaseAcquired+15$3.11+$46.6513,103Direct
Aug 6, 2021Common StockPPurchaseAcquired+15$3.01+$45.1513,118Direct
Aug 9, 2021Common StockPPurchaseAcquired+15$2.93+$43.9513,133Direct
Aug 10, 2021Common StockPPurchaseAcquired+15$2.96+$44.413,148Direct
Aug 11, 2021Common StockPPurchaseAcquired+15$2.98+$44.713,163Direct
Aug 13, 2021Common StockPPurchaseAcquired+15$2.92+$43.813,178Direct
Aug 16, 2021Common StockPPurchaseAcquired+15$2.92+$43.813,193Direct
Aug 17, 2021Common StockPPurchaseAcquired+15$3.05+$45.7513,208Direct
Aug 18, 2021Common StockPPurchaseAcquired+15$2.97+$44.5513,223Direct
Aug 19, 2021Common StockPPurchaseAcquired+15$3.02+$45.313,238Direct
Aug 20, 2021Common StockPPurchaseAcquired+15$2.96+$44.413,253Direct
Aug 23, 2021Common StockPPurchaseAcquired+15$2.87+$43.0513,268Direct
Aug 24, 2021Common StockPPurchaseAcquired+15$2.89+$43.3513,283Direct
Aug 25, 2021Common StockPPurchaseAcquired+15$2.79+$41.8513,298Direct
Aug 26, 2021Common StockPPurchaseAcquired+15$2.82+$42.313,313Direct
Aug 27, 2021Common StockPPurchaseAcquired+15$2.84+$42.613,328Direct
Aug 30, 2021Common StockPPurchaseAcquired+15$2.88+$43.213,343Direct
Aug 31, 2021Common StockPPurchaseAcquired+15$2.93+$43.9513,358Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)